Healthcare & Biotech Updates
Aardvark Therapeutics (NASDAQ: AARD) reported its full year 2024 results, with its lead candidate ARD-101 showing promising Phase 2 outcomes in Prader‑Willi Syndrome. The IPO raised $97.9 million, leaving the company with a cash position of $73.7 million and key trial milestones on the horizon.
Biomea Fusion (BMEA) posted strong Q4 and FY2024 results driven by its focus on diabetes and obesity programs. An interim CEO was appointed while its COVALENT-111 study demonstrated a notable 1.47% HbA1c reduction in severe insulin‑deficient patients.
Vivos Therapeutics (NASDAQ: VVOS) delivered solid FY2024 results, with revenue up 9% to $15.0 million and a critical FDA 510(k) clearance for its DNA appliance targeting pediatric obstructive sleep apnea – a pivotal step toward improved profitability.
CytoSorbents (NASDAQ: CTSO) posted robust Q4 performance with product revenue of $9.2 million and full‑year revenue of $35.6 million. A successful rights offering and improved operating metrics set the stage for key upcoming regulatory decisions.
Glucotrack (NASDAQ: GCTK) reported transformative FY2024 results as it advanced from preclinical to clinical stage. The company completed its first human clinical study of its continuous blood glucose monitor, meeting its primary endpoint while securing $16.3 million in funding for its planned FDA IDE approval in Q4 2025.
Technology, Industrial & Security Innovations
Spire Global (NYSE: SPIR) announced its Q4 and full‑year 2024 results, registering $110.5 million in annual revenue with 13% year‑over‑year growth. Its upcoming AI‑powered space exploration mission is expected to boost satellite data services.
Duos Technologies Group (DUOT) delivered transformative Q4 and FY2024 outcomes, highlighted by a landmark $42 million contract and rising recurring services revenue that sets the stage for projected revenue growth of 285–312% in 2025.
ReliaQuest raised over $500 million in its latest funding round, achieving a valuation of $3.4 billion. Its integrated GreyMatter platform now supports over 200 cybersecurity tools, driving more than 30% year‑over‑year growth.
Microvast Holdings (NASDAQ: MVST) reported record FY2024 revenue of $379.8 million – up 23.9% year‑over‑year – with Q4 revenue reaching $113.4 million and improved gross margins climbing to 36.6%. A robust backlog of $401.3 million reinforces future demand.
STMicroelectronics (NYSE: STM) and its partner Innoscience (HKEX:02577.HK) inked a strategic agreement for GaN technology development that will leverage ST’s manufacturing capacity and Innoscience’s 8‑inch GaN‑on‑Si expertise to advance power solutions across multiple sectors.
CPI Aerostructures (CVU) reported its Q4 and full‑year 2024 financial results, noting a slight revenue decline to $81.1 million from $86.5 million in 2023, alongside operational improvements, reduced debt, and a strong backlog of $510 million from new program awards.
Karman Space & Defense (NYSE: KRMN) announced an extension of its 10K filing date due to delayed audit activities following its February IPO. Affirming strong preliminary 2024 performance, the company will release full-year results on April 8, 2025, with a conference call set for 1:30 PM PDT.
Energy, Financial & Commodities Transactions
PVH Corp (NYSE: PVH) reported Q4 2024 revenue of $2.372 billion with robust gross margins. In a strategic move, the company announced a $500 million accelerated share repurchase (ASR) agreement to buy back approximately 14% of its outstanding shares.
Binah Capital Group (NASDAQ: BCG) posted Q4 revenue growth of 8% to $45 million and boosted assets under management by 13% to $27 billion, reflecting a successful refinancing and market repositioning post–public listing.
WEX Inc (NYSE: WEX) completed its tender offer by repurchasing nearly 4.87 million shares at $154.00 each, totaling roughly $750 million in share buybacks and underscoring strong investor confidence.
The Timken Company (NYSE: TKR) announced a swift CEO transition with Richard G. Kyle named interim CEO after a record year generating $4.6 billion in sales, as the Board begins its search for a permanent leader.
FMC Corporation (NYSE: FMC) unveiled a strategic partnership with Bayer to introduce Isoflex™ active herbicide technology to European markets, targeting 30 million planted hectares across key crops.
Excelerate Energy (NYSE: EE) initiated a proposed public offering of Class A common stock valued at $150 million to fund its $1.055 billion acquisition of New Fortress Energy’s Jamaica business, marking a decisive expansion into green energy assets.
Valaris (NYSE: VAL) secured a significant two‑year contract for its drillship VALARIS DS‑10 worth $352 million, with extension options potentially adding another $350 million to its backlog, reinforcing its market position in offshore services.
Freeport (FCX) provided its Q1 2025 operational update, noting that consolidated copper sales met guidance at approximately 850 million pounds, while gold sales are projected to trail by about 100,000 ounces relative to estimates, amid a temporary rise in net cash costs.
Battalion Oil Corporation (NYSE: BATL) released its Q4 2024 financials with average daily production at 12,750 Boe/d (55% oil) and operating revenue of $49.7 million. Despite a Q4 net loss of $30.9 million, the company concluded its six‐well campaign under budget and has already drilled four wells for its 2025 plan.
Sandstorm Gold Royalties (NYSE: SAND) announced that its Hod Maden joint venture in Türkiye approved early‑works capital investments between US$60–100 million for 2025, reinforcing its long‑term outlook with a critical focus on road and tunnel construction at the project.
Wheaton Precious Metals filed its Form 40‑F with the SEC and detailed plans for its Annual and Special Meeting of Shareholders on May 9, 2025. The filing, now available on EDGAR, offers transparency into its 2024 audited statements and future outlook in the mining sector.
Soho House & Co (NYSE: SHCO) reported Q4 and FY2024 results with Q4 total revenues reaching $305.6 million and FY revenues climbing to $1,203.8 million. Despite a net loss of $163.0 million for the fiscal year, the company is evaluating a privatization offer at $9.00 per share, adding a layer of market intrigue.
SolarMax Technology (NASDAQ: SMXT) reported a steep decline in 2024, with revenue falling to $23.0 million from $54.1 million and a substantial net loss of $35.0 million. The performance was driven by regulatory and market shifts in the residential solar segment, prompting plans to target commercial and industrial projects.
Endeavour Silver (NYSE: EXK) is progressing with its Terronera Project in Jalisco, Mexico, having produced the first batch of concentrate during initial commissioning. With wet commissioning slated for early Q2 2025, the company is focused on finalizing tailing filter installations and pipeline connections to advance production.
